BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37904674)

  • 1. Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group.
    Caminati M; Fassio A; Alberici F; Baldini C; Bello F; Cameli P; Conticini E; Cottin V; Crimi C; Dagna L; Delvino P; Deroux A; Duran E; Espigol-Frigole G; Karadag O; Maule M; Moiseev S; Monti S; Moroni L; Padoan R; Pugnet G; Taille C; Toniati P; Vaglio A; Emmi G
    Allergy; 2024 Feb; 79(2):516-519. PubMed ID: 37904674
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe Asthma Where Eosinophilic Granulomatosis with Polyangiitis Became Apparent after the Discontinuation of Dupilumab.
    Ikeda M; Ohshima N; Kawashima M; Shiina M; Kitani M; Suzukawa M
    Intern Med; 2022 Mar; 61(5):755-759. PubMed ID: 34393172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Onset of eosinophilic granulomatosis with polyangiitis (EGPA) after anti-Th2 biotherapy initiation in severe asthma patients: Report of 3 cases.
    Fargeas M; Devouassoux G; Gerfaud-Valentin M
    Respir Med Res; 2024 Jun; 85():101070. PubMed ID: 38141578
    [No Abstract]   [Full Text] [Related]  

  • 4. New-onset of eosinophilic granulomatosis with polyangiitis without eosinophilia and eosinophilic infiltration under benralizumab treatment: A case report.
    Yonezawa H; Ohmura SI; Ohkubo Y; Otsuki Y; Miyamoto T
    Mod Rheumatol Case Rep; 2023 Dec; 8(1):145-149. PubMed ID: 37243733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study.
    Nolasco S; Portacci A; Campisi R; Buonamico E; Pelaia C; Benfante A; Triggiani M; Spadaro G; Caiaffa MF; Scioscia G; Detoraki A; Valenti G; Papia F; Tomasello A; Crimi N; Scichilone N; Pelaia G; Carpagnano GE; Crimi C
    Front Immunol; 2023; 14():1204444. PubMed ID: 37457743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of monoclonal antibodies targeting type 2 inflammation for severe asthma and eosinophilic granulomatosis with polyangiitis.
    Davanzo F; Marchi MR; Iorio L; Bortoli M; Doria A; Padoan R
    Autoimmun Rev; 2024 Mar; 23(3):103503. PubMed ID: 38101691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benralizumab as a Steroid-Sparing Treatment Option in Eosinophilic Granulomatosis with Polyangiitis.
    Guntur VP; Manka LA; Denson JL; Dunn RM; Dollin YT; Gill M; Kolakowski C; Strand MJ; Wechsler ME
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1186-1193.e1. PubMed ID: 33065367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologics for eosinophilic granulomatosis with polyangiitis.
    Caminati M; Maule M; Bello F; Emmi G
    Curr Opin Allergy Clin Immunol; 2023 Feb; 23(1):36-43. PubMed ID: 36413432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term Safety and Efficacy of Benralizumab for Eosinophilic Granulomatosis with Polyangiitis Complicated with Severe Neuropathy.
    Koga Y; Yoshimi S; Harada T; Suzuki S; Ohtsuka T; Dobashi K; Hisada T
    Intern Med; 2023 May; 62(10):1553-1556. PubMed ID: 36171130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophilic granulomatosis polyangiitis (EGPA) complicated with periaortitis, precipitating role of dupilumab? A case report a review of the literature.
    Kai M; Vion PA; Boussouar S; Cacoub P; Saadoun D; Le Joncour A
    RMD Open; 2023 Sep; 9(3):. PubMed ID: 37673442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Torasemide-induced Vascular Purpura in the Course of Eosinophilic Granulomatosis with Polyangiitis.
    Frątczak A; Polak K; Miziołek B; Bergler-Czop B
    Acta Dermatovenerol Croat; 2022 Sep; 30(2):116-118. PubMed ID: 36254546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Benralizumab in cases of eosinophilic granulomatosis with polyangiitis].
    Carrette A; Mercier V; Lelubre C; Peché R
    Rev Mal Respir; 2022 Sep; 39(7):621-625. PubMed ID: 35909008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
    Quan MV; Frankel SK; Maleki-Fischbach M; Tan LD
    BMC Pulm Med; 2018 Nov; 18(1):181. PubMed ID: 30497438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid effect of benralizumab in exacerbation of severe eosinophilic asthma associated with eosinophilic granulomatosis with polyangiitis.
    Martínez-Rivera C; Garcia-Olivé I; Urrutia-Royo B; Basagaña-Torrento M; Rosell A; Abad J
    BMC Pulm Med; 2021 Jan; 21(1):35. PubMed ID: 33478439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophilic granulomatosis with polyangiitis developed after dupilumab administration in patients with eosinophilic chronic rhinosinusitis and asthma: a case report.
    Suzaki I; Tanaka A; Yanai R; Maruyama Y; Kamimura S; Hirano K; Kobayashi H
    BMC Pulm Med; 2023 Apr; 23(1):130. PubMed ID: 37076824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review of Anti-IL-5 Therapies for Eosinophilic Granulomatosis with Polyangiitis.
    Koike H; Nishi R; Yagi S; Furukawa S; Fukami Y; Iijima M; Katsuno M
    Adv Ther; 2023 Jan; 40(1):25-40. PubMed ID: 36152266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-IL-5 in severe asthma associated with eosinophilic granulomatosis with polyangiitis. Real-life study].
    Akdime F; Habib S; Regard L; Terrier B; Cohen P; Mouthon L; Guillevin L; Burgel PR; Honore I; Puéchal X; Roche N
    Rev Mal Respir; 2023; 40(9-10):732-742. PubMed ID: 37923651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the pharmacotherapeutic management of eosinophilic granulomatosis with polyangiitis.
    Pagnoux C; Berti A
    Expert Opin Pharmacother; 2023; 24(11):1269-1281. PubMed ID: 37204027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophilia Induced by Blocking the IL-4/IL-13 Pathway: Potential Mechanisms and Clinical Outcomes.
    Olaguibel JM; Sastre J; Rodríguez JM; Del Pozo V
    J Investig Allergol Clin Immunol; 2022 Jun; 32(3):165-180. PubMed ID: 35522053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful benralizumab for eosinophilic myocarditis in eosinophilic granulomatosis with polyangiitis.
    Belfeki N; Abroug S; Ghriss N; Chouchane I; Hamrouni S; Strazzulla A; Zayet S
    Clin Exp Rheumatol; 2021 Oct; 40(4):834-837. PubMed ID: 35522541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.